Item 8.01. Other Events.

As set forth in the December 19, 2012 Form 8-K of Markel Corporation ("Markel") filed with the Securities and Exchange Commission (the "SEC"), on December 18, 2012, Markel entered into an Agreement and Plan of Merger (the "Merger Agreement") with Alterra Capital Holdings Limited ("Alterra") and Commonwealth Merger Subsidiary Limited, a direct wholly owned subsidiary of Markel ("Merger Sub"), under which Merger Sub will merge with and into Alterra (the "Merger"), with Alterra as the surviving company (the "Surviving Company") becoming a wholly owned subsidiary of Markel.

On February 8, 2013, Alterra stockholder Louisiana Municipal Police Employees Retirement System (the "Plaintiff") filed a complaint in the United States District Court for the Southern District of New York, purportedly on behalf of itself and other stockholders of Alterra, against Alterra, Alterra's board of directors, Markel and Merger Sub. The complaint alleges in relevant part that the joint proxy statement filed by Alterra and Markel on January 18, 2013 omits allegedly material information in violation of Section 14(a) of the Securities Exchange Act of 1934 ("Section 14(a)"). Plaintiff simultaneously requested leave to file a motion for preliminary injunction seeking to enjoin the vote of Alterra stockholders on the proposed merger on the basis of the alleged violation of Section 14(a). Markel believes that plaintiff's claims are without merit. On February 15, 2013, the parties entered into a settlement agreement in which Alterra agreed to make certain supplemental disclosures to its stockholders and on February 15, 2013 Alterra filed with the SEC Supplement no. 1 to Alterra's definitive joint proxy statement/prospectus ("Supplement no. 1"), which supplements the definitive joint proxy statement/prospectus on Schedule 14A filed with the SEC by Alterra on January 18, 2013.

A copy of this Supplement no. 1 is filed as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No. Description

99.1 Supplement no. 1 to Alterra's definitive joint proxy statement/prospectus dated February 15, 2013.

---